This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Clinical Investigation of New Ostomy Appliances

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Coloplast A/S
ClinicalTrials.gov Identifier:
NCT01523756
First received: January 10, 2012
Last updated: January 28, 2014
Last verified: January 2014
Results First Received: November 21, 2013  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Crossover Assignment;   Masking: Open Label
Condition: Leakage
Interventions: Device: test product 1: new ostomy base plate with Coloplast as manufacturer
Device: test product 2: new ostomy base plate with Coloplast as manufacturer

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
The subjects were recruited through the Coloplast database.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Own Product (Baseline) - Test Product 1 - Test Product 2

own product (baseline) - test product 1 - test product 2

test product 1 = New ostomy base plate. Due to company confidentiality the product is just called test product 1

Own Product (Baseline) - Test Product 2 - Test Product 1

own product (baseline) - test product 2 - test product 1

test product 2 = New ostomy base plate. Due to company confidentiality the product is just called test product 2


Participant Flow for 3 periods

Period 1:   Baseline Period
    Own Product (Baseline) - Test Product 1 - Test Product 2   Own Product (Baseline) - Test Product 2 - Test Product 1
STARTED   11   9 
COMPLETED   11   8 
NOT COMPLETED   0   1 
Adverse Event                0                1 

Period 2:   Test Period 1
    Own Product (Baseline) - Test Product 1 - Test Product 2   Own Product (Baseline) - Test Product 2 - Test Product 1
STARTED   11   8 
COMPLETED   10   8 
NOT COMPLETED   1   0 
Adverse Event                1                0 

Period 3:   Test Period 2
    Own Product (Baseline) - Test Product 1 - Test Product 2   Own Product (Baseline) - Test Product 2 - Test Product 1
STARTED   10   8 
COMPLETED   10   7 
NOT COMPLETED   0   1 
Withdrawal by Subject                0                1 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Overall Study No text entered.

Baseline Measures
   Overall Study 
Overall Participants Analyzed 
[Units: Participants]
 20 
Age 
[Units: Years]
Mean (Standard Deviation)
 64  (10.8) 
Gender 
[Units: Participants]
 
Female   12 
Male   8 


  Outcome Measures

1.  Primary:   Leakage Under the Base Plate Using a 24-point Scale   [ Time Frame: Each product will be tested 2 weeks ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Marianne Raff
Organization: Coloplast A7S
phone: +45 4911 2562
e-mail: dkmr@oloplast.com



Responsible Party: Coloplast A/S
ClinicalTrials.gov Identifier: NCT01523756     History of Changes
Other Study ID Numbers: CP226
Study First Received: January 10, 2012
Results First Received: November 21, 2013
Last Updated: January 28, 2014